American International Group, Inc. Tcr2 Therapeutics Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.11 - $2.94 $31,951 - $44,520	-15,143 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.4 - $4.71 $2,560 - $5,025	-1,067 Reduced 6.58%	15,143 $42,000
Q4 2021 Feb 11, 2022	SELL	$4.58 - $8.34 $2,221 - $4,044	-485 Reduced 2.91%	16,210 $76,000
Q3 2021 Nov 12, 2021	SELL	$8.44 - $18.35 $3,350 - $7,284	-397 Reduced 2.32%	16,695 $142,000
Q2 2021 Aug 13, 2021	BUY	$16.41 - $24.71 $3,643 - $5,485	222 Added 1.32%	17,092 $280,000
Q1 2021 May 07, 2021	BUY	$20.38 - $34.07 $42,838 - $71,615	2,102 Added 14.23%	16,870 $372,000
Q4 2020 Feb 12, 2021	SELL	$19.0 - $32.63 $8,037 - $13,802	-423 Reduced 2.78%	14,768 $457,000
Q3 2020 Nov 04, 2020	BUY	$13.1 - $20.69 $68,499 - $108,188	5,229 Added 52.49%	15,191 $309,000
Q2 2020 Aug 12, 2020	BUY	$6.51 - $16.85 $19,712 - $51,021	3,028 Added 43.67%	9,962 $153,000
Q1 2020 May 04, 2020	SELL	$6.01 - $16.01 $2,410 - $6,420	-401 Reduced 5.47%	6,934 $54,000
Q4 2019 Feb 05, 2020	SELL	$12.17 - $17.88 $754 - $1,108	-62 Reduced 0.84%	7,335 $105,000
Q3 2019 Nov 08, 2019	BUY	$10.15 - $19.53 $63,620 - $122,414	6,268 Added 555.18%	7,397 $111,000
Q2 2019 Aug 13, 2019	BUY	$13.64 - $20.97 $15,399 - $23,675	1,129 New	1,129 $16,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.